About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,806 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,806 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1161-1180 of 10,806 trials

CompletedA Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for MpoxThis study is a Phase 2 open-label, non-placebo controlled, multi-site clinical trial that will evaluate the standard SC regimen in adolescents ages 12 through 17 years…NCT05740982·Birmingham, Alabama and 17 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

Active not recruitingAn Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström MacroglobulinemiaThe purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics, and activity of acalabrutinib in treating subjects with WM.NCT02180724·Santa Barbara, California and 37 others

CompletedStudy of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic MalignanciesThis is an open-label, multicenter, dose-escalation Phase 1/1b study in patients with acute myelogenous leukemia (AML)/MDS or non-Hodgkin Lymphoma (NHL), intended to investigate…NCT02543879·Los Angeles, California and 7 others

TerminatedVaccine-Based Immunotherapy Regimen For NSCLC and TNBCPart 1of the study will evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenicity of increasing doses of a vaccine-based immunotherapy regimen (VBIR-2) for…NCT03674827·Encinitas, California and 33 others

Active not recruitingSafety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®The purpose of this trial is to assess the safety and efficacy of the Xoft Axxent eBx System when used for single-fraction IORT in early stage breast cancer.NCT01644669·Tucson, Arizona and 23 others

CompletedA Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530This was a long-term follow-up study to evaluate the durability of sustained virologic response (SVR), persistence of direct-acting antiviral agent (DAA) resistance, and clinical…NCT02441283·Dothan, Alabama and 41 others

RecruitingA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of BGB-B2033 alone or in…NCT06427941·Birmingham, Alabama and 50 others

CompletedA Study of A-101 Topical Solution for the Treatment of Common WartsPhase 3 Study of A-101 Topical Solution in Subjects with Common WartsNCT03691831·Glendale, Arizona and 23 others

TerminatedAcute Cough Study In Children15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6…NCT01257542·Pinellas Park, Florida and 3 others

RecruitingObservational Study of Pediatric Rheumatic Diseases: The CARRA RegistryContinuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases.NCT02418442·Birmingham, Alabama and 81 others

CompletedIrofulven in Treating Children With Recurrent or Refractory Solid TumorsPhase I trial to study the effectiveness of irofulven in treating children with recurrent or refractory solid tumors.NCT00003370·Little Rock, Arkansas and 55 others

Enrolling by invitationLong-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to…NCT05127954·Huntsville, Alabama and 112 others

CompletedDual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected PeopleRitonavir (RTV) is a protease inhibitor (PI) commonly used to increase drug levels of other PIs in HIV drug treatment.NCT00028366·Los Angeles, California and 12 others

CompletedThe Angel® Catheter Pivotal Clinical TrialThe primary objective of this multicenter, prospective, single arm clinical trial is to evaluate the safety and effectiveness of the Angel® Catheter in subjects at high risk of…NCT02186223·Los Angeles, California and 20 others

UnknownTwo-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly AfliberceptThis study is designed to evaluate the safety and efficacy of every 2 week intravitreal aflibercept injections in a population of neovascular AMD patients that have demonstrated…NCT03468296·Nashville, Tennessee

CompletedACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory…NCT04843761·Tucson, Arizona and 39 others

TerminatedAn Evaluation of Patient Reported Outcomes and Clinical OutcomesThis extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D…NCT06092970·Huntsville, Alabama and 38 others

Active not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsThis is a Phase 1, open-label, dose-escalation and expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect on…NCT03845166·Duarte, California and 85 others

RecruitingA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate CancerThe purpose of this study is to evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-1261 in participants with advanced or metastatic prostate cancer.NCT07567846·Scottsdale, Arizona and 4 others

TerminatedOpen-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative ColitisThe purpose of this study is to allow subjects completing study LYC-30937-2001 the opportunity to receive LYC-30937-EC 25 mg.NCT02764229·Little Rock, Arkansas and 39 others

PreviousPage 59 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville